Why is Plexus repurchasing shares while investing heavily in growth?

Plexus is repurchasing shares from a position of operational strength—the company generated record Q3 revenue of $1.305 billion and improved its ROIC to 14.9%, which exceeds its 9.0% weighted average cost of capital. While the company noted it expects a usage of free cash flow for fiscal 2026 to support revenue growth investments, the $100 million repurchase program reflects management's confidence in future cash generation and its commitment to returning capital to long-term shareholders alongside reinvestment.

How much of the repurchase authorization has been used?

As of the end of Q3 fiscal 2026, Plexus had repurchased $78.6 million of the $100 million authorized program (year-to-date cash outflow was $64.1 million, with Q3 repurchases of $20.6 million). Only $21.4 million remains available under the current authorization, meaning the company has deployed approximately 79% of its authorized capacity.

What was the average price paid for the shares in Q3?

Plexus repurchased shares at an average price of $258.75 per share during fiscal Q3. The filing does not disclose the trading range or number of shares repurchased, only the dollar amount ($20.6 million) and average price.

Will Plexus continue repurchasing after the current authorization is nearly exhausted?

The filing does not indicate whether Plexus intends to seek a new authorization once the current $100 million program is depleted. Historically, repurchase-focused companies typically request board approval for new programs as prior authorizations near completion. Shareholders and investors should monitor future SEC filings or investor presentations for any new authorization announcements.

How do these repurchases affect Plexus's share count and EPS?

Repurchasing shares reduces the outstanding share count, which mechanically increases diluted EPS when net income is held constant. Plexus reported weighted average diluted shares of 27.3 million for Q3 fiscal 2026, down from 27.5 million in the prior-year quarter, reflecting the cumulative effect of repurchases. Over time, lower share count supports higher per-share metrics if operating performance remains steady or improves.

PLXS 8-K Filed 2026-07-29 Execution disclosure

Plexus repurchased $20.6M in shares at $258.75 average in Q3

Electronics manufacturer continues $100M program with $21.4M remaining under authorization.

Avg price paid$258.75

Remaining$21M

MechanismNot specified

What the filing says

Plexus Corp. (NASDAQ: PLXS) repurchased approximately $20.6 million of its common stock at an average price of $258.75 per share during its fiscal third quarter ended July 4, 2026, as reported in its earnings press release filed on July 29, 2026.

The repurchases were executed under the company's $100 million 2026 Share Repurchase Program. Following the Q3 activity, $21.4 million remains available under the existing authorization. The filing does not disclose the specific execution mechanism (such as Rule 10b-18 open-market purchases, 10b5-1 plan, or other method) employed for these repurchases.

Year-to-date through Q3 fiscal 2026, Plexus repurchased $64.1 million of common stock, as disclosed in the condensed consolidated statements of cash flows. The company reported record fiscal third quarter revenue of $1.305 billion, GAAP diluted EPS of $1.58, and non-GAAP diluted EPS of $2.32.

Purchased $20.6 million of our shares at an average price of $258.75 per share under our 2026 Share Repurchase Program, leaving $21.4 million available under our existing $100.0 million authorization. — PLEXUS CORP 8-K filing · View on SEC EDGAR →

What this means

Plexus has deployed roughly one-fifth of its authorized repurchase capacity during the first nine months of fiscal 2026, with $64.1 million repurchased year-to-date at an average price of approximately $258.75 per share in Q3. The company's return of capital via buybacks reflects confidence in its cash generation and financial position, supported by strong operational performance—record Q3 revenue, healthy ROIC of 14.9%, and a favorable 62-day cash cycle. With only $21.4 million remaining on a $100 million authorization, Plexus may seek board approval for a new program in the coming quarters if it wishes to continue systematic repurchases.

Frequently asked questions

Why is Plexus repurchasing shares while investing heavily in growth?: Plexus is repurchasing shares from a position of operational strength—the company generated record Q3 revenue of $1.305 billion and improved its ROIC to 14.9%, which exceeds its 9.0% weighted average cost of capital. While the company noted it expects a usage of free cash flow for fiscal 2026 to support revenue growth investments, the $100 million repurchase program reflects management's confidence in future cash generation and its commitment to returning capital to long-term shareholders alongside reinvestment.
How much of the repurchase authorization has been used?: As of the end of Q3 fiscal 2026, Plexus had repurchased $78.6 million of the $100 million authorized program (year-to-date cash outflow was $64.1 million, with Q3 repurchases of $20.6 million). Only $21.4 million remains available under the current authorization, meaning the company has deployed approximately 79% of its authorized capacity.
What was the average price paid for the shares in Q3?: Plexus repurchased shares at an average price of $258.75 per share during fiscal Q3. The filing does not disclose the trading range or number of shares repurchased, only the dollar amount ($20.6 million) and average price.
Will Plexus continue repurchasing after the current authorization is nearly exhausted?: The filing does not indicate whether Plexus intends to seek a new authorization once the current $100 million program is depleted. Historically, repurchase-focused companies typically request board approval for new programs as prior authorizations near completion. Shareholders and investors should monitor future SEC filings or investor presentations for any new authorization announcements.
How do these repurchases affect Plexus's share count and EPS?: Repurchasing shares reduces the outstanding share count, which mechanically increases diluted EPS when net income is held constant. Plexus reported weighted average diluted shares of 27.3 million for Q3 fiscal 2026, down from 27.5 million in the prior-year quarter, reflecting the cumulative effect of repurchases. Over time, lower share count supports higher per-share metrics if operating performance remains steady or improves.

execution electronics-manufacturing rule-10b-18 fiscal-2026

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.